Fleeman T L, Cappon G D, Chapin R E, Hurtt M E
Pfizer Global Research and Development, Groton, Connecticut 06340, USA.
Birth Defects Res B Dev Reprod Toxicol. 2005 Oct;74(5):442-9. doi: 10.1002/bdrb.20056.
Given the role of nutrition and body weight gain in normal development, pharmaceuticals intended to reduce appetite and promote weight loss will generate safety data that may be challenging to interpret. To aid with this, the effects of feed restriction and subsequent body weight reductions on embryo-fetal development were investigated in the rat.
Groups of 20 timed pregnant female Sprague-Dawley rats were offered Certified Rodent Diet 5002 either ad libitum or in restricted amounts of 20, 15, 10, and 7.5 g/day from Gestation Day (GD) 6-17. Clinical signs, body weights, and food consumption were recorded. Cesarean sections were performed on GD 21 and fetuses were sexed, weighed, and examined for external, visceral, and skeletal development.
Mean maternal body weights at the end of the feed restriction period, GD 18, were reduced 0.87 x, 0.80 x, 0.69 x, and 0.63 x control mean in the 20, 15, 10, and 7.5 g/day groups, respectively. Mean body weight gains for the restriction period inclusive, GD 6-18, were 0.49 x and 0.24 x control at 10 and 7.5 g/day, respectively, and a mean body weight loss occurred at 10 and 7.5 g/day (0.95 x and 0.85 x mean GD 6 body weight, respectively). Fetal body weights were reduced 0.95 x, 0.93 x, 0.90 x, and 0.76 x control at 20, 15, 10, and 7.5 g/day, respectively. This resulted in a reduction in gravid uterine weight at 10 and 7.5 g/day. There were no external, visceral, or skeletal malformations attributed to feed restriction. There was an increase in the skeletal variation of wavy ribs and a decrease in ossification at 7.5 g/day.
These data demonstrate that feed restriction-induced reductions in maternal gestational body weight gain of approximately 50% compared to ab lib fed rats only caused a reduction in fetal body weight. Even up to a 15% maternal gestational body weight loss had no effect on embryo viability in rats, but retarded fetal growth significantly enough to induce minor changes in skeletal development. There were no external, visceral, or skeletal malformations associated with any of the levels of maternal body weight reduction or loss.
鉴于营养和体重增加在正常发育中的作用,旨在降低食欲和促进体重减轻的药物所产生的安全数据可能难以解释。为了辅助对此进行研究,在大鼠中研究了饲料限制和随后的体重减轻对胚胎 - 胎儿发育的影响。
将20只定时怀孕的雌性Sprague-Dawley大鼠分为几组,从妊娠第6天至第17天,一组随意进食认证啮齿动物饮食5002,其他组分别给予20、15、10和7.5克/天的限量饮食。记录临床体征、体重和食物摄入量。在妊娠第21天进行剖宫产,对胎儿进行性别鉴定、称重,并检查其外部、内脏和骨骼发育情况。
在饲料限制期结束时,即妊娠第18天,20、15、10和7.5克/天组的母鼠平均体重分别比对照组平均体重降低了0.87倍、0.80倍、0.69倍和0.63倍。包括限制期在内,即妊娠第6天至第18天,10和7.5克/天组的平均体重增加分别为对照组的0.49倍和0.24倍,并且在10和7.5克/天组出现了平均体重减轻(分别为妊娠第6天平均体重的0.95倍和0.85倍)。在20、15、10和7.5克/天组,胎儿体重分别比对照组降低了0.95倍、0.93倍、0.90倍和0.76倍。这导致在10和7.5克/天组妊娠子宫重量减轻。没有发现归因于饲料限制的外部、内脏或骨骼畸形。在7.5克/天组,波浪状肋骨的骨骼变异增加,骨化减少。
这些数据表明,与随意进食的大鼠相比,饲料限制导致母鼠妊娠期体重增加减少约50%,仅引起胎儿体重降低。即使母鼠妊娠期体重减轻高达15%,对大鼠胚胎活力也没有影响,但足以显著延缓胎儿生长,从而在骨骼发育中引起轻微变化。与任何母鼠体重减轻或降低水平均未发现有外部、内脏或骨骼畸形相关。